{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:01:51Z","timestamp":1788544911767,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["3332021048"],"award-info":[{"award-number":["3332021048"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bmcl.2022.128975","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T18:17:45Z","timestamp":1662401865000},"page":"128975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Synthesis and biological evaluation of novel N, N\u2032-diarylurea derivatives as potent antibacterial agents against MRSA"],"prefix":"10.1016","volume":"75","author":[{"given":"Xiaonan","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongying","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefu","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128975_b0005","doi-asserted-by":"crossref","first-page":"FSO290","DOI":"10.4155\/fsoa-2017-0109","article-title":"Antimicrobial resistance mechanisms and potential synthetic treatments","volume":"4","author":"Ali","year":"2018","journal-title":"Future Sci OA"},{"key":"10.1016\/j.bmcl.2022.128975_b0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bmcl.2022.128975_b0015","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1574-6976.2011.00284.x","article-title":"Population biology of gram-positive pathogens: High-risk clones for dissemination of antibiotic resistance","volume":"35","author":"Willems","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bmcl.2022.128975_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-1358-0_1","article-title":"Worldwide clinical demand for antibiotics: Is it a real countdown?","volume":"2296","author":"Barreiro","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmcl.2022.128975_b0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","article-title":"Antibiotic resistance","volume":"10","author":"Frieri","year":"2017","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.bmcl.2022.128975_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: No eskape! An update from the infectious diseases society of america","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2022.128975_b0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1473-3099(15)70072-1","article-title":"New antibiotic development hailed as game changing","volume":"15","author":"Kirby","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmcl.2022.128975_b0040","first-page":"171","article-title":"Counting the dead and what they died from: An assessment of the global status of cause of death data","volume":"83","author":"Mathers","year":"2005","journal-title":"Bull WHO"},{"key":"10.1016\/j.bmcl.2022.128975_b0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: A global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.bmcl.2022.128975_b0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.idc.2016.02.004","article-title":"Multidrug-resistant bacteria in the community: Trends and lessons learned","volume":"30","author":"Van Duin","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bmcl.2022.128975_b0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2022.128975_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/nyas.14254","article-title":"Molecular epidemiology and mechanisms of antibiotic resistance in enterococcus spp., staphylococcus spp., and streptococcus spp. In africa: A systematic review from a one health perspective","volume":"1465","author":"Osei Sekyere","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bmcl.2022.128975_b0065","first-page":"768","article-title":"Vancomycin resistant enterococci: A brief review","volume":"68","author":"Raza","year":"2018","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.bmcl.2022.128975_b0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eimc.2013.08.001","article-title":"infections caused by multi-resistant gram-positive bacteria (staphylococcus aureus and enterococcus spp.)] [J","volume":"31","author":"Cant\u00f3n","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.bmcl.2022.128975_b0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0213-005X(17)30028-9","article-title":"update on antibiotic resistance in gram-positive bacteria]","volume":"35","author":"Lozano","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.bmcl.2022.128975_b0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmcl.2022.128975_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1396906","article-title":"Combination antibiotic treatment of serious methicillin-resistant staphylococcus aureus infections","volume":"36","author":"Davis","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.bmcl.2022.128975_b0090","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.idc.2021.07.002","article-title":"Vancomycin-resistant enterococci: Epidemiology, infection prevention, and control","volume":"35","author":"Joshi","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bmcl.2022.128975_b0095","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: The who priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmcl.2022.128975_b0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ja.2016.72","article-title":"Antibiotics in the clinical pipeline at the end of 2015","volume":"70","author":"Butler","year":"2017","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bmcl.2022.128975_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127799","article-title":"Recent advances in antibacterial agents","volume":"35","author":"Kong","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2022.128975_b0110","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bcp.2005.12.016","article-title":"Empirical antibacterial drug discovery\u2014foundation in natural products","volume":"71","author":"Singh","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2022.128975_b0115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/jcp.24291","article-title":"Effects of low concentrations of regorafenib and sorafenib on human hcc cell afp, migration, invasion, and growth in vitro","volume":"228","author":"Carr","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bmcl.2022.128975_b0120","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/jcp.25014","article-title":"Grp78\/dna k is a target for nexavar\/stivarga\/votrient in the treatment of human malignancies, viral infections and bacterial diseases","volume":"230","author":"Roberts","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bmcl.2022.128975_b0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41557-019-0378-7","article-title":"Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant staphylococcus aureus, persisters and biofilms","volume":"12","author":"Le","year":"2020","journal-title":"Nat Chem"},{"key":"10.1016\/j.bmcl.2022.128975_b0130","article-title":"In vitro and in vivo activity of a novel sorafenib derivative sc5005 against mrsa","volume":"71","author":"Chang","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22004516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22004516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:46:37Z","timestamp":1760773597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22004516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":26,"alternative-id":["S0960894X22004516"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128975","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel N, N\u2032-diarylurea derivatives as potent antibacterial agents against MRSA","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128975"}}